<DOC>
	<DOCNO>NCT00620464</DOCNO>
	<brief_summary>The primary purpose study demonstrate bioequivalence IMPLANON Radiopaque IMPLANON .</brief_summary>
	<brief_title>A Bioequivalence Study IMPLANON Radiopaque IMPLANON ( 34528 ) ( P05720 )</brief_title>
	<detailed_description />
	<mesh_term>Etonogestrel</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<criteria>At least 18 old 40 year age time screen Good physical mental health Regular cycle usual length 24 35 day Body mass index ≥ 18 ≤ 29 Willing give inform consent write Contraindications : know suspected pregnancy active venous thromboembolic disorder ( e.g . deep vein thrombosis , pulmonary embolism ) presence history severe hepatic disease long liver function value return normal malignancy premalignancy , sex steroidinfluenced undiagnosed vaginal bleeding hypersensitivity component Implanon/Radiopaque Implanon Hypertension , i.e . systolic blood pressure &gt; 140 mmHg and/or diastolic blood pressure &gt; 90 mmHg . A history pregnancy previous use sex steroid : jaundice and/or severe pruritus related cholestasis ; gallstone formation ; porphyria ; systemic lupus erythematosus ; haemolytic uraemic syndrome ; Sydenham 's chorea ; herpes gestationis ; otosclerosisrelated hearing loss Present use use 2 month prior start Implanon/Radiopaque Implanon one follow drug : phenytoin , phenobarbital , primidone , carbamazepine , rifampicin , oxcarbazepine , topiramate , felbamate , ritonavir , nelfinavir , griseofulvin herbal remedy St John 's wort . Administration investigational drug within 2 month prior start Implanon/Radiopaque Implanon</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>